Related Experiment Video
Updated: Apr 15, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Difficult clinical situations in the antiphospholipid syndrome
Renata Ferreira Rosa1, Michelle Remião Ugolini-Lopes, Audrey Krüse Zeinad-Valim
1Rheumatology Division, São Paulo University, Av. Dr. Arnaldo 455, third floor, room 3190, São Paulo, Brazil, renatafrosa@hotmail.com.
Antiphospholipid syndrome (APS) presents challenges beyond typical thrombosis and pregnancy issues. This review focuses on managing difficult non-criteria manifestations and refractory treatments in APS for better clinical decision-making.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Antiphospholipid syndrome (APS) is defined by antiphospholipid antibodies (aPL) linked to thrombosis and pregnancy complications.
- Beyond established criteria, APS encompasses diverse non-criteria manifestations causing significant morbidity.
- Refractory treatment scenarios in APS pose complex clinical challenges often lacking detailed guidance.
Purpose of the Study:
- To review the management strategies for difficult clinical situations in Antiphospholipid Syndrome.
- To provide evidence-based information aiding clinicians in managing complex APS cases.
- To address challenging non-criteria manifestations and refractory treatment options in APS.
Main Methods:
- Literature review focusing on clinical management of APS.
- Analysis of non-criteria manifestations and their treatment.
- Evaluation of approaches to refractory APS cases.
Main Results:
- Non-criteria manifestations significantly increase APS morbidity.
- Specific management protocols for certain non-criteria manifestations are discussed.
- Strategies for refractory APS cases are presented, offering potential therapeutic avenues.
Conclusions:
- Effective management of difficult APS cases requires addressing non-criteria manifestations and refractory treatments.
- This review provides a framework for clinical decision-making in complex APS scenarios.
- Further research is needed to optimize treatment for challenging APS presentations.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
08:54Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis IV: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies